Sanofi officially extends Genzyme tender; Lundbeck chairman to step down;

@FiercePharma: Patent cliff jeopardizes $250B in sales through 2015. Story | Follow @FiercePharma

> French drugmaker Sanofi-Aventis has officially extended its offer for all outstanding shares of U.S. biotech Genzyme until April 1 from March 16. News

> Danish drugmaker Lundbeck said its chairman of the board, Per Wold-Olsen, would not seek re-election at the company's upcoming shareholders' meeting. Report

> A Boston federal court has certified a class action lawsuit against McKesson on behalf of municipalities that sued the drug distributor in 2008 for alleged drug overcharges. Story

> Activist hedge fund Elliott Advisors said it has launched a website to help investors in Europe's biggest biotech Actelion vote at the company's shareholder meeting. Article

> A fierce battle is being waged between retail pharmacists and mail-order companies over where people should be able to fill their long-term prescriptions. Story

> Belgian pharmaceutical group UCB launched perpetual subordinated bonds worth €300 million ($419.7 million) to further improve its financial structure. Item

> A switch in focus from talk therapy to medications has swept psychiatric practices and hospitals, leaving many older psychiatrists feeling unhappy and inadequate. News

> Ista Pharmaceuticals filed a petition with FDA, asking it to refrain from approving a generic form of a discontinued cataract drug using the original labeling. Article

> TestPak, a pharmaceutical packaging and repackaging company based in Whippany, NJ, has merged with three other companies and changed its name. Story

Biotech News

@FierceBiotech: Pfizer's blockbuster RA hopeful clears a Ph3 hurdle. News | Follow@FierceBiotech

@JohnCFierce: Lilly's neuroscience chief wasn't kicked out, he was recruited by J&J. Article | Follow @JohnCFierce

> Fact or Fantasy? Investigators estimate new drug R&D at $55M. Story 

> NYT: Big Pharma hits the panic button as new programs fail to deliver. Report

> Biogen scouting for new hematology programs to buy, license. Article 

> AZ opens its R&D cupboards to Galderma in dermatology pact. News

> Genzyme's Termeer to pocket up to $221M. Item

 Biotech IT News

> Former MS programmer assails software patents. Report 

> Contractors tap SharePoint as EDM platform. Article 

> Indiana site connects researchers with trial subjects. News 

> Oracle rouses Phase Forward in coding release. Report 

> SAS, JMP visualize safety review data. Item 

> App combo links imaging, randomization. Story

Medical Device News

> Accuray to buy TomoTherapy for $277M. News 

> Japan's Terumo buys Caridian for $2.6B. Article 

> Medtronic launches Achieve Mapping Catheter in Europe. Story 

> Aussie firms look to make bionic eye as Argus II gets EU OK. Report

> NASA tech reduces common chemo side effect. Item

And Finally... After hours, Sanofi-Aventis chemist Antonio Ramos puts his skill set to a different use: developing formulas for Brooklyn Soda Works, the artisanal soda company he started last year with his partner. Report